Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

Regeneron acquires 23andMe's genetics services for (Dollar) 256 million * Customer privacy safeguards will remain in place ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal. Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended ...

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.

Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...

Alert: Your DNA Is At Risk in This New Age of Increased Surveillance** The recent sale of the genetic data company 23andMe to Regeneron Pharmaceuticals has raised significant concerns about the ...